Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes

Details for Australian Patent Application No. 2002304717 (hide)

Owner Wilex AG

Inventors Schmitt, Manfred; Muhlenweg, Bernd; Magdolen, Viktor; Luther, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2002304717

PCT Number PCT/EP02/03799

PCT Pub. Number WO2002/082077

Priority 101 17 381.4 06.04.01 DE

Filing date 5 April 2002

Wipo publication date 21 October 2002

Acceptance publication date 23 August 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 35/56 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from animals other than mammals or birds

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

C12R 1/91 (2006.01)

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 101 17 381.4 06.04.01 DE

10 April 2003 Application Open to Public Inspection

  Published as AU-B-2002304717

23 August 2007 Application Accepted

  Published as AU-B-2002304717

20 December 2007 Standard Patent Sealed

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002304718-Impact resistant modified blends made of polyethylenterephthalate and at least one polycarbonate based on dihydroxydiarylcyclohexane

2002304716-FLAME-RETARDANT, ANTI-STATIC POLYCARBONATE MOULDING COMPOUNDS